Filing Details

Accession Number:
0001411690-22-000023
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-08-17 17:55:28
Reporting Period:
2022-08-15
Accepted Time:
2022-08-17 17:55:28
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1411690 Bionano Genomics Inc. BNGO Laboratory Analytical Instruments (3826) 261756290
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1810930 Yvonne Linney C/O Bionano Genomics, Inc.
9540 Towne Centre Drive, Suite 100
San Diego CA 92121
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-08-15 20,000 $0.38 20,000 No 4 M Direct
Common Stock Disposition 2022-08-15 20,000 $3.62 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2022-08-15 20,000 $0.00 20,000 $0.38
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
60,923 2030-05-04 No 4 M Direct
Footnotes
  1. The shares vest in equal monthly installments over a three year period such that the option is fully vested on May 4, 2023, subject to full vesting acceleration upon a change in control (as defined in Bionano Genomic's equity incentive plan).